Dominik Lysek, PhD

Chief Science Officer

Dominik Lysek, PhD, MChem is a trained chemist, with a PhD in structural biology as well as a successful entrepreneur. After leading the clinical research group in a biomaterial company, he founded credentis in January 2010, in order to established the first biomimetic technology to treat dental caries and enable the Guided Enamel Remineralisation Therapy. Throughout the decade Dr. Lysek was the CEO, raised multiple financing rounds, developed a whole portfolio of products and finally had a successful exit in November 2020. Today, he works as an angel investor and is on the board of healthcare companies as well as philanthropic foundations. Dr. Lysek is passionate about bringing cutting-edge scientific innovations into the oral care field, and turning them into commercial successes.

Partner with us

Shape the Future of Oral Health

Revere Partners is dedicated to co-creating the future of oral health by investing in and supporting the most innovative companies in the industry. We believe in the power of partnership and are committed to working closely with founders and investors to drive meaningful change in the oral health landscape.

Connect with us to explore investments and partnership opportunities — and join us in defining the future of oral health.

Contact Us